Explore how peanut avoidance guidelines led to a rise in peanut allergies, and discover why early exposure is now recommended to reduce allergy risks.

Due to the extreme mis-pricing I argue Indivior offers investors great risk/reward asymmetry. Find out why INDV stock is a ...

The phase 3 clinical trial is a randomized, double-blind, three-arm study comparing MELT-300, sublingual midazolam, and ...

Biotin Sublingual Spray and Melatonin Sublingual Spray to help consumers tackle health issues that come with today’s ...

While vaccines such as Uromune may not be an accessible or perfect solution for everyone they offer real hope for people ...

Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the ...

Rapid epinephrine absorption with a time to reach the 100 pg/mL threshold concentration in 9 minutes after dosingSustained pharmacokinetics (PK) ...

VANCOUVER, BC / ACCESSWIRE / October 7, 2024 / ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased to announce that Terry Lynch has joined the BioNxt team as a capital markets ...

The global allergy immunotherapy market is projected to reach USD 1.74 billion in 2023, with robust growth expected over the ...

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

Autumn is the season of change. It's also the season of hay fever, or allergic rhinitis. So how can people with fall ...